Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype

Behavioural Brain Research

Volumn 222, Issue 2, 2011, Pages 332-341

  Aydin, Cigdem ^a   Oztan, Ozge ^a   Isgor, Ceylan ^a  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Behavioral sensitization; Central nucleus of amygdala; Hippocampus; Medial amygdala; Negative affect; Y2R antagonist

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; JNJ 31020028; MESSENGER RNA; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; LOCOMOTION; MALE; MEDIAL AMYGDALA; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; SOCIAL PHOBIA; SYSTEMIC THERAPY; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME;

AMYGDALA; ANIMALS; ANXIETY; BENZAMIDES; CA3 REGION, HIPPOCAMPAL; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; INTERPERSONAL RELATIONS; MALE; MOTOR ACTIVITY; NEUROPEPTIDE Y; NICOTINE; PHENOTYPE; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROPEPTIDE Y; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 79955951006     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.03.067     Document Type: Article

References (54)

1. Andrews N., File S.E., Fernandes C., Gonzalez L.E., Barnes N.M. Evidence that the median raphé nucleus - dorsal hippocampal pathway mediates diazepam withdrawal-induced anxiety. Psychopharmacology (Berl) 1997, 130:228-234.
2. Aydin C., Oztan O., Isgor C. Vulnerability to nicotine abstinence-related social anxiety-like behavior: Molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor. Neurosci Lett 2011, 490:220-225.
3. Bacchi F., Mathé A.A., Jiménez P., Stasi L., Arban R., Gerrard P., et al. Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides 2006, 27:3202-3207.
4. Benwell M.E., Balfour D.J. Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles. Psychopharmacology (Berl) 1979, 63:7-11.
5. Bhatti A.S., Hall P., Ma Z., Tao R., Isgor C. Hippocampus modulates the behaviorally-sensitizing effects of nicotine in a rat model of novelty-seeking: potential role for mossy fibers. Hippocampus 2007, 17:922-933.
6. Bhatti A.S., Aydin C., Oztan O., Ma Z., Hall P., Tao R., et al. Effects of a cannabinoid receptor (CB) 1 antagonist AM251 on behavioral sensitization to nicotine in a rat model of novelty-seeking behavior: correlation with hippocampal 5HT. Psychopharmacology (Berl) 2009, 203:23-32.
7. Brennauer A., Dove S., Buschauer A. Structure-activity relationships of nonpeptide neuropeptide Y receptor antagonists. Handb Exp Pharmacol 2004, 162:505-546.
8. Caberlotto L., Fuxe K., Hurd Y.L. Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum. J Chem Neuroanat 2000, 20:327-337.
9. Chae Y., Yeom M., Han J.H., Park H.J., Hahm D.H., Shim I., et al. Effect of acupuncture on anxiety-like behavior during nicotine withdrawal and relevant mechanisms. Neurosci Lett 2008, 430:98-102.
10. Cippitelli A., Rezvani A.H., Robinson J.E., Eisenberg L., Levin E.D., Bonaventure P., et al. The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety. Alcohol 2010, 1-10.
11. Ellinwood E.H., Sudilovsky A., Nelson L.M. Evolving behavior in the clinical and experimental amphetamine (model) psychosis. Am J Psychiatry 1973, 130:1088-1093.
12. Eva C., Mele P., Collura D., Nai A., Pisu M.G., Serra M., et al. Modulation of neuropeptide Y and Y1 receptor expression in the amygdala by fluctuations in the brain content of neuroactive steroids during ethanol drinking discontinuation in Y1R/LacZ transgenic mice. J Neurochem 2008, 104:1043-1054.
13. George O., Ghozland S., Azar M.R., Cottone P., Zorrilla E.P., Parsons L.H., et al. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc Natl Acad Sci USA 2007, 104:17198-17203.
14. Gonzalez L.E., Ouagazzal A.M., File S.E. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphé reveals differential GABAergic control in two animal tests of anxiety. Eur J Neurosci 1998, 10:3673-3680.
15. Heilig M., Koob G.F., Ekman R., Britton K.T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci 1994, 17:80-85.
16. Irvine E.E., Cheeta S., File S.E. Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. Behav Pharmacol 1999, 10:691-697.
17. Irvine E.E., Bagnalasta M., Marcon C., Motta C., Tessari M., File S.E., et al. Nicotine self-administration and withdrawal: modulation of anxiety in the social interaction test in rats. Psychopharmacology (Berl) 2001, 153:315-320.
18. Kalivas P.W., Sorg B.A., Hooks M.S. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 1993, 4:315-334.
19. Kask A., Harro J. Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304. Neuropharmacology 2000, 39:1292-1302.
20. Kask A., Harro J., von Hörsten S., Redrobe J.P., Dumont Y., Quirion R. The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y. Neurosci Biobehav Rev 2002, 26:259-283.
21. Klapstein G.J., Colmers W.F. 4-Aminopyridine and low Ca2+ differentiate presynaptic inhibition mediated by neuropeptide Y, baclofen and 2-chloroadenosine in rat hippocampal CA1 in vitro. Br J Pharmacol 1992, 105:470-474.
22. King P.J., Widdowson P.S., Doods H.N., Williams G. Regulation of neuropeptide Y release by neuropeptide Y receptor ligands and calcium channel antagonists in hypothalamic slices. J Neurochem 1999, 73:641-646.
23. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
24. Koob G.F., Le Moal M. Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 2005, 8:1442-1444.
25. Koob G., Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 2007, 164:1149-1159.
26. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
27. Koob G.F., Le Moal M. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci 2008, 363:3113-3123.
28. Kreek M.J., Koob G.F. Drug dependence: stress and dysregulation of brain reward pathways. Drug Alcohol Depend 1998, 51:23-47.
29. Lieberman J.A., Kinon B.J., Loebel A.D. Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 1990, 16:97-110.
30. Lin E.J., Lin S., Aljanova A., During M.J., Herzog H. Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice. Eur Neuropsychopharmacol 2010, 20:164-175.
31. McQuiston A.R., Colmers W.F. Neuropeptide Y2 receptors inhibit the frequency of spontaneous but not miniature EPSCs in CA3 pyramidal cells of rat hippocampus. J Neurophysiol 1996, 76:3159-3168.
32. Nakajima M., Inui A., Asakawa A., Momose K., Ueno N., Teranishi A., et al. produces anxiety via Y2-type receptors. Peptides 1998, 19:359-363.
33. Naveilhan P., Neveu I., Arenas E., Ernfors P. Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system. Neuroscience 1998, 87:289-302.
34. Pandey S.C. Anxiety and alcohol abuse disorders: a common role for CREB and its target, the neuropeptide Y gene. Trends Pharmacol Sci 2003, 24:456-460.
35. Pandey S.C., Ugale R., Zhang H., Tang L., Prakash A. Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci 2008, 28:3729-3737.
36. Parker S.L., Balasubramaniam A., Neuropeptide Y Y2 receptor in health and disease. Br J Pharmacol 2008, 153:420-431.
37. Richter R.M., Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 1999, 32:254-261.
38. Rimondini R., Thorsell A., Heilig M. Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neurosci Lett 2005, 375:129-133.
39. Rylkova D., Boissoneault J., Isaac S., Prado M., Shah H.P., Bruijnzeel A.W. Effects of NPY and the specific Y1 receptor agonist [d-His(26)]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats. Neuropeptides 2008, 42:215-227.
40. Sato M., Chen C.C., Akiyama K., Otsuki S. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis. Biol Psychiatry 1983, 18:429-440.
41. Sato M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann N Y Acad Sci 1992, 654:160-170.
42. Schroeder J.P., Olive F., Koenig H., Hodge C.W. Intra-amygdala infusion of the NPY Y1 receptor antagonist BIBP 3226 attenuates operant ethanol self-administration. Alcohol Clin Exp Res 2003, 27:1884-1891.
43. Sherer M.A., Kumor K.M., Cone E.J., Jaffe J.H. Suspiciousness induced by 4h intravenous infusions of cocaine. Preliminary findings. Arch Gen Psychiatry 1988, 45:673-677.
44. Shoblock J.R., Welty N., Nepomuceno D., Lord B., Aluisio L., Fraser I., et al. In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor. Psychopharmacology (Berl) 2010, 208:265-277.
45. Silva A.P., Carvalho A.P., Carvalho C.M., Malva J.O. Modulation of intracellular calcium changes and glutamate release by neuropeptide Y1 and Y2 receptors in the rat hippocampus: differential effects in CA1, CA3 and dentate gyrus. J Neurochem 2001, 79:286-296.
46. Slawecki C.J., Thorsell A.K., El Khoury A., Mathé A.A., Ehlers C.L. Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior. Neuropeptides 2005, 39:369-377.
47. Sparta D.R., Fee J.R., Knapp D.J., Breese G.R., Thiele T.E. Elevated anxiety-like behavior following ethanol exposure in mutant mice lacking neuropeptide Y (NPY). Drug Alcohol Depend 2007, 90:297-300.
48. Thorsell A., Michalkiewicz M., Dumont Y., Quirion R., Caberlotto L., Rimondini R., et al. Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci USA 2000, 97:12852-12857.
49. Thorsell A. Neuropeptide Y (NPY) in alcohol intake and dependence. Peptides 2007, 28:480.
50. Tschenett A., Singewald N., Carli M., Balducci C., Salchner P., Vezzani A., et al. Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 2003, 18:143-148.
51. Tu B., Timofeeva O., Jiao Y., Nadler J.V. Spontaneous release of neuropeptide Y tonically inhibits recurrent mossy fiber synaptic transmission in epileptic brain. J Neurosci 2005, 25:1718-1729.
52. Tu B., Jiao Y., Herzog H., Nadler J.V. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: correlation with Y2 receptor plasticity. Neuroscience 2006, 143:1085-1094.
53. Qian J., Colmers W.F., Saggau P. Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry. J Neurosci 1997, 17:8169-8177.
54. Zhang H., Pandey S.C. Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal. Peptides 2003, 24:1397-1402.